Taylor Glen a10% owner
4
Filed Feb 17, 2026Period of report Feb 12, 20260001104659-26-016182
| Transaction | Security | Shares | Price | ValueValue (shares × price) | Held after | Ownership |
|---|---|---|---|---|---|---|
PurchaseFeb 12, 2026 | Class A Common Stock | 18,750,000 | $0.40 | $7.50M | 21,703,607 | Direct |
Filing footnotes · 5
- F1The Reporting Person is the owner and chairman of Taylor Sports Group.
- F2GAT Funding, LLC is an entity controlled by Reporting Person.
- F3The Series A-1 Warrants and Series A-2 Warrants (the "Common Warrants") will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Common Warrants (the "Stockholder Approval Date").
- F4The Series A-1 Warrants expire on the earlier of (i) the twenty-four month anniversary of the Stockholder Approval Date and (ii) thirty days following the date the Company publicly announces that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration for its Acclaim cochlear implant (the "Series A-1 Milestone Event").
- F5The Series A-2 Warrants expire on the earlier of (i) the sixty-month anniversary of the Stockholder Approval Date and (ii) thirty days following the date the Company publicly announces that it has received U.S. Food and Drug Administration approval for its Acclaim cochlear implant (the "Series A-2 Milestone Event").